Guidance for Implementing a Remote Assessment Strategy as a Protocol Adaptation During the COVID-19 Pandemic Date Published: May 08, 2020 Whitepaper This white paper offers guidance on implementing remote ratings for studies operating during the COVID-19 crisis. Signant Health experts, Dan Debonis and Gary Sachs, discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty. Learn about the important considerations regarding: Legal & regulatory needs Operations Clinical requirements Logistics Safety Engagement Download Now Share: LinkedInTweet Recommended Resources 3 Themes and Takeaways From FDA’s Draft Guidance on DCTs Download Now Whitepaper Computerized Adaptive Tests Using PROMIS CAT Download Now Whitepaper The EMA Recommendation Paper on Decentralized Elements in Clinical Trials: An Overview Read Our White Paper Whitepaper